William Burke

William Burke

DirectoratHaemonetics· In proxies 2021–2025

Pay in FY2023-85% from the year before

William Burke was paid $550.6K in FY2023 (Apr), down 85%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Haemonetics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. AxogenPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  2. HaemoneticsPublic company · 5 yr
    • Executive Vice President, Chief Financial Officer (through April 11, 2022)2021 – Present · 5 yrNo stock prices for these years
  3. MiroMatrixPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • AxogenDirector · 3 yr on the boardIndependentAudit (Chair), Governance, Nominating and Sustainability—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?